TC BioPharm (Holdings) plc (NASDAQ: TCBP)
$0.4080
+0.0030 ( -3.77% ) 664.0K
TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform. Harnessing the innate ability of GD-Ts has enabled the company to develop a range of clinical-stage cell therapies designed to combat cancer and viral infection.
Market Data
Open
$0.4080
Previous close
$0.4050
Volume
664.0K
Market cap
$3.23M
Day range
$0.3810 - $0.4300
52 week range
$0.3487 - $26.1600
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 6-k | Form 6-K | 5 | Dec 17, 2024 |
| 6-k | Form 6-K | 7 | Dec 16, 2024 |
| 6-k | Form 6-K | 70 | Nov 25, 2024 |
| 6-k | Form 6-K | 1 | Oct 11, 2024 |
| 6-k | Form 6-K | 5 | Aug 30, 2024 |
| 6-k | Form 6-K | 1 | Aug 23, 2024 |
| 6-k | Form 6-K | 5 | Aug 15, 2024 |
| 6-k | Form 6-K | 4 | Aug 08, 2024 |
| 6-k | Form 6-K | 1 | Aug 06, 2024 |
| 6-k | Form 6-K | 1 | Jul 29, 2024 |